A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions

Healthy

Interventions

DRUG

Sertraline HCl 100 mg tablets, single dose

A: Experimental SSubjects received Purepac formulated products under fasting conditions

DRUG

Zoloft® 100 mg tablets, single dose

B: Active comparator Subjects received Pfizer formulated products under fasting conditions

Trial Locations (1)

CEDRA Clinical Research, LLC, Austin